FDA Approved: TELMISARTAN — Supplemental Application (Chartwell RX, LLC.)

View source ↗

Summary

FDA grants supplemental approval for Telmisartan (ANDA078710) filed by Chartwell RX, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Telmisartan (Telmisartan)

Snippet

SUPPL AP for TELMISARTAN (TELMISARTAN)